Immunofluorescent Zo-1 Occludin Claudin
Immunofluorescent Zo-1 Occludin Claudin - Related Videos
09:56
Immunofluorescence Microscopy: Immunofluorescence Staining of Paraffin-Embedded Tissue Sections
0 Views •
2023
Source: Thomas Chaffee1, Thomas S. Griffith2,3,4, and Kathryn L. Schwertfeger1,3,4 1 Department of Lab Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455 2 Department of Urology, University of Minnesota, Minneapolis, MN 55455 3 Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455 4 Center for Immunology, University of Minnesota, Minneapolis, MN 55455 Pathologic analyses of tissue sections can be used to obtain a better understanding of normal tissue...
09:32
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
0 Views •
Cited by 16 •
2018
Studying tumor microenvironment may identify prognostic or predictive biomarkers of clinical response to immunotherapy. Presented here, is an innovative method based on in situ fluorescence multispectral imaging to analyze and count automatically various subpopulations of CD8+ T cells. This reproducible and reliable technique is suitable for large cohort analyses.
09:13
Quantitative Immunofluorescence to Measure Global Localized Translation
0 Views •
Cited by 4 •
2017
This manuscript describes a method to visualize and quantify localized translation events in subcellular compartments. The approach proposed in this manuscript requires a basic confocal imaging system and reagents and is rapid and cost-effective.
06:40
Temporal Analysis of the Nuclear-to-cytoplasmic Translocation of a Herpes Simplex Virus 1 Protein by Immunofluorescent Confocal Microscopy
0 Views •
Cited by 1 •
2018
ICP0 undergoes nuclear-to-cytoplasmic translocation during HSV-1 infection. The molecular mechanism of this event is not known. Here we describe the use of confocal microscope as a tool to quantify ICP0 movement in HSV-1 infection, which lays the groundwork for quantitatively analyzing ICP0 translocation in future mechanistic studies.
01:12
Immunofluorescence Microscopy
0 Views •
2023
A fluorescence microscope uses fluorescent chromophores called fluorochromes, which can absorb energy from a light source and then emit this energy as visible light. Fluorochromes include naturally fluorescent substances (such as chlorophylls) and fluorescent stains that are added to the specimen to create contrast. Dyes such as Texas red and FITC are examples of fluorochromes. Other examples include the nucleic acid dyes 4’,6’-diamidino-2-phenylindole (DAPI), and acridine orange. The...
FAQs
An intact barrier typically shows organized, continuous labeling along cell-cell borders, whereas disrupted junctions may appear fragmented, irregular, or less prominent. Interpreting all three markers together can reveal whether barrier-associated proteins remain coordinately localized or show different patterns of change. These spatial differences provide evidence of altered cellular organization rather than relying only on overall fluorescence abundance.
Localization shows where tight-junction proteins are positioned within cells and tissues, while abundance reflects the strength of their detected signal. A protein may remain detectable but become discontinuous or displaced from cell-cell borders, indicating organizational changes that total fluorescence could overlook. This distinction is important when evaluating barrier effects associated with inflammation, infection, drugs, or pathology.
Cell-cell borders are the relevant spatial context for assessing junctional organization because the method reveals whether ZO-1, occludin, and claudin form continuous patterns between neighboring cells. Comparing border-associated labeling across samples helps connect molecular distribution with barrier integrity. Loss of continuity or altered border localization can therefore support an interpretation of impaired cellular barrier organization.
Researchers can compare fluorescence patterns between conditions, focusing on signal abundance, border continuity, and the distribution of each junctional protein. For example, samples exposed to an inflammatory, infectious, pharmacological, or pathological condition can be evaluated against a comparison condition. The resulting differences help identify whether the tested factor is associated with preserved, reduced, or disorganized barrier features.
The workflow begins with cells or tissue, followed by fixation to preserve structure and permeabilization to allow antibody access. Primary antibodies are then applied to bind ZO-1, occludin, and claudin, followed by fluorescently labeled secondary antibodies that generate detectable signals. Microscopy is used afterward to visualize and compare junctional patterns across the prepared samples.
Analysis should assess both the amount of detected signal and its spatial arrangement, especially along cell-cell borders. Investigators can examine whether labeling is continuous, fragmented, reduced, or otherwise altered among samples. Comparing these features across conditions provides a visual basis for relating tight-junction changes to cellular barrier organization and potential tissue pathology.
This approach is useful when a study needs to connect molecular changes in junction-associated proteins with barrier-related cellular or tissue effects. Supported applications include investigations of inflammation, infection, drug effects, and tissue pathology. By documenting changes in protein distribution and border continuity, imaging can help characterize how these conditions affect epithelial or endothelial barrier organization.
Epithelial and endothelial barriers depend on organized cell-cell junctions, so altered ZO-1, occludin, or claudin patterns can provide molecular evidence of structural disturbance. Imaging tissue or cultured cells allows investigators to examine these changes in their cellular context. The findings can support pathology studies by linking disrupted junctional organization with impaired barrier integrity.